As part of the INVICTA project, Oncosyne recently hosted a project seminar with clinical collaborators from Sahlgrenska University Hospital. The meeting was held at Oslo Cancer Cluster and focused on how our tumoroid-based technology can support improved treatment outcomes for patients with pancreatic cancer. The project is progressing well and we are well on track with our objectives.
The discussions highlighted key clinical challenges and how our platform can be adapted to better meet patient needs.
We work closely to ensure our tumoroid-based platform supports relevant clinical needs and contributes to more effective and personalized cancer care.
We appreciate the valuable input from all participants and look forward to continued collaboration. It is both inspiring and useful to discuss the clinical challenges this specific patient group has. We believe it is key to help deliver them the best and most optimal cancer care.